Novel Injectable Hydrogel Technology Featured in Drug Discovery News

A recent article in Drug Discovery News highlights a new injectable hydrogel technology and its potential to provide painless defibrillation for patients with ventricular arrhythmias. The flexible conductive “wires” are the result of an ongoing collaboration between research teams led by Mehdi Razavi, MD, at The Texas Heart Institute, and Elizabeth Cosgriff-Hernandez, PhD, at The University of Texas at Austin. The investigators believe the conductive hydrogels can be used to eliminate the painful shocks associated with current methods used to reset a patient’s heart rhythm, improving their quality of life.

The article features an interview about the technology with The Institute’s Allison Post, PhD, Associate Director of Electrophysiology Clinical Research & Innovations, and commentary from biomedical engineer Karen Christman, PhD, from the University of California, San Diego.